SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is surging to new all-time highs, triggering excitement and discussions about potential targets like $130k-$150k this week. Community members are attributing the rally to factors like a potential supply shortage, institutional buying, and the start of 'Uptober', while also speculating about a possible short squeeze. Many are also pointing to Bitcoin's role as a safe haven amid economic uncertainty.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the community discusses its potential for further gains, fueled by upcoming catalysts like ETF staking and possible rate cuts. Community members are debating market manipulation and potential price targets, while some express concerns about recent price action. Broader context includes discussions about Ethereum's market share, comparisons to other tokens, and its role in the evolving crypto landscape.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals ($CRML) is trending due to speculation around potential U.S. government investment in its Greenland rare earths mine, spurred by reports of government interest and comparisons to similar deals involving other companies. The community is discussing the potential impact of government backing, particularly a possible equity stake, and how this could affect the valuation of $CRML and its majority owner, European Lithium ($EULIF). Some are also focused on warrant prices and trading strategies around potential price spikes.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users share links to its website, Telegram, X community, and DEX Screener. The community emphasizes Weedcoin's steady growth and compares it to Bitcoin, highlighting the cultural relevance of cannabis. Chatter includes the phrases:  'like Bitcoin but way higher'.

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

LGND is trending as investors evaluate its royalty-based biopharma model and pipeline valuation, with discussions focusing on revenue and EPS multiples compared to peers. The community is also closely monitoring unusual options activity and recent analyst target price adjustments, including Oppenheimer's upgrade to $190. The stock has recently hit new five-year highs, fueling speculation about future growth potential and potential overvaluation.

LXP Industrial Trust is a real estate investment trust, which engages in financing, acquisition, and ownership of a portfolio of single-tenant warehouse and distribution properties. Its properties are located in Ohio, Indiana, South Carolina, Georgia, and Arizona. The company was founded by E. Robert Roskind in October 1993 and is headquartered in West Palm Beach, FL.

LXP Industrial Trust

LXP Industrial Trust is trending due to unusual options activity, specifically a large bullish call flow, sparking discussions around potential upside. Community members are also weighing in on the industrial REIT's performance, its sensitivity to interest rates, and key support levels. JMP Securities updated their rating to Market Perform and Keybanc updated their rating to Overweight, target set at 11.

Super X AI Technology Ltd. engages in providing artificial intelligence infrastructure solutions. It offers integrated systems that include computation, model hosting, data pipelines, and orchestration tools to facilitate enterprise AI deployment on a global scale. The company was founded on August 25, 2021, and is headquartered in Singapore.

Super X AI Technology Ltd

Super X AI Technology is trending due to the launch of its new XN9160-B200 AI server powered by NVIDIA Blackwell GPUs, boasting significant performance improvements. The community is actively debating the company's legitimacy, with some users pointing to its past as an interior design firm and expressing concerns about potential rug pulls and short reports, while others highlight major partnerships and potential for significant gains.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

ANRO is trending due to positive sentiment around its FDA Fast Track designation for ALTO-101, a potential treatment for cognitive impairment in schizophrenia, with the community discussing the possibility of a short squeeze and significant upside potential. Some traders are highlighting the company's strong cash position and upcoming clinical trial readouts as reasons for optimism. Others point to technical indicators and institutional ownership as factors influencing the stock's movement.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Space and Airborne Systems, Integrated Mission Systems, Communication Systems, and Aerojet Rocketdyne. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne and cyber domains. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land and sea domains. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

L3Harris Technologies is trending due to positive momentum driven by defense spending and key contract wins, including a significant deal for Javelin propulsion systems. The community is discussing the company's potential for growth within the aerospace and defense technology sector, particularly with strong institutional accumulation and expansion into areas like missile defense and secure communications. Some analysts believe it's undervalued, while others point to LEAPS options activity as a reason for the upward trend.

Epsium Enterprise Ltd. operates as a holding company, which engages in import trading and distribution of wines and spirits. It offers a range of products, including Chinese liquor, French cognac, Scottish whisky, fine wines, champagne, and other miscellaneous alcoholic beverages. Its brands include Moutai, Xijiu, Wuliangye, Remy Martin Cognac, Macallan, Cointreau, Piper Heidsieck Champagne, French Fine Wines, Red and White Wines. The company was founded by Son I Tam on March 24, 2020 and is headquartered in Macau.

Epsium Enterprise Ltd. - Ordinary Shares - Class A

Epsium Enterprise Ltd.

Epsium Enterprise ($EPSM) is trending due to significant price volatility and mentions of a potential short squeeze, drawing comparisons to other recent high-flying, low-float IPOs. Community chatter highlights the stock's small float, high short interest, and its association with Hong Kong/Chinese stocks, leading to speculation about further dramatic price swings. Traders are actively discussing entry and exit points, while also cautioning about the risks associated with potential pump-and-dump schemes.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders

Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s...

Aeterna Zentaris Announces Merger Approval

Aeterna Zentaris Inc. (TSE:AEZS) has released an update. Aeterna Zentaris Inc. has received final court approval to merge with Ceapro Inc. in a str...

Ceapro Inc. Finalizes Merger with Aeterna Zentaris

Ceapro Inc (TSE:CZO) has released an update. Ceapro Inc. has received final court approval for its all-stock merger with Aeterna Zentaris, with com...

Ceapro receives final court approval for merger with Aeterna Zentaris

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to...

TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to announce...

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( Aeterna ) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to...

TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( Aeterna ) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ( Ceapro ) are pleased to announce...

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

ISS states in its Aeterna Zentaris FOR recommendation that on balance, the deal has strong strategic merit, third party solicitation was unable to generate any other actionable proposals, and...

COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. It operates through the Active Ingredient and Biopharmaceutical segments. The Active Ingredient segment is involved in the development of proprietary extraction technologies. The Biopharmaceutical segment includes commercializing and developing pharmaceutical therapeutics and diagnostic tests. The company was founded on September 12, 1990 and is headquartered in Toronto, Canada.

COSCIENS Biopharma Inc.

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

AEZS
Aeterna Zentaris Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest AEZS News

AEZS Aeterna Zentaris Inc.